Search

Your search keyword '"Bura‐Riviere, A."' showing total 447 results

Search Constraints

Start Over You searched for: Author "Bura‐Riviere, A." Remove constraint Author: "Bura‐Riviere, A."
447 results on '"Bura‐Riviere, A."'

Search Results

1. Risk of recurrence after discontinuing anticoagulation in patients with COVID-19- associated venous thromboembolism: a prospective multicentre cohort studyResearch in context

2. Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia

3. Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism

4. Risk of recurrence after discontinuing anticoagulation in patients with COVID-19- associated venous thromboembolism: a prospective multicentre cohort study

5. COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding

7. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

8. Update About the Management of Low-Density Lipoprotein Cholesterol and Hypertriglyceridemia in Lower Extremity Peripheral Artery Disease Patients: Consensus of the French Society of Vascular Medicine and the French Society for Vascular and Endovascular Surgery

10. A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism

11. A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism

13. Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registry

15. Risk of recurrence after discontinuing anticoagulation in patients with COVID-19- associated venous thromboembolism: a prospective multicentre cohort study

17. Timing and characteristics of venous thromboembolism after noncancer surgery

18. 25 mm Hg versus 35 mm Hg elastic compression stockings to prevent post-thrombotic syndrome after deep vein thrombosis (CELEST): a randomised, double-blind, non-inferiority trial

20. Rivaroxaban vs Dalteparin in Cancer-Associated Thromboembolism: A Randomized Trial

22. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

23. Predictors of use of direct oral anticoagulants in patients with venous thromboembolism: Findings from the Registro Informatizado Enfermedad Tromboembólica registry

25. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

27. French recommendations for the management of Takayasu’s arteritis

28. Disparities Between International Guidelines (AHA/ESC/ESVS/ESVM/SVS) Concerning Lower Extremity Arterial Disease: Consensus of the French Society of Vascular Medicine (SFMV) and the French Society for Vascular and Endovascular Surgery (SCVE)

29. Comparative clinical prognosis of massive and non‐massive pulmonary embolism: A registry‐based cohort study

30. Symptomatic subsegmental versus more central pulmonary embolism: Clinical outcomes during anticoagulation

31. Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia

32. Proposal of the French Society of Vascular Medicine for the prevention, diagnosis and treatment of venous thromboembolic disease in outpatients with COVID-19

33. Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry

34. A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism

35. Real life results of direct-acting oral anticoagulants recommended-dose in obese vs normal-weight patients with venous thromboembolism

36. Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registry

38. Evaluation of the predictive value of the bleeding prediction score VTE‐BLEED for recurrent venous thromboembolism

44. Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism

46. First three months of anticoagulation for venous thromboembolism in non-cancer patients: LMWH VS. VKAs. Findings from the RIETE registry

48. Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism

49. French practical guidelines for the diagnosis and management of relapsing polychondritis

Catalog

Books, media, physical & digital resources